For several decades now, science has kept a close eye on ibogaine—the main psychoactive alkaloid found in the iboga plant (Tabernanthe iboga). This isn’t your typical psychedelic. Researchers initially focused on how it might help people kick substance use disorders (SUD). But the scope is widening. Fresh data hints that ibogaine’s reach goes much deeper, showing promise for post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), eating disorders, and even traumatic brain injury (TBI).

We built this space for clinicians, academic minds, and curious onlookers alike. It serves as a direct window into where ibogaine science stands right now. Here, you will find raw breakdowns of how the molecule affects the brain, current clinical trials, essential safety protocols, and its shifting global legal status.